Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 382 followers
Latest posts
Last updated about 5 hours ago
ESMO: Merck spotlights details of Keytruda's landmark win in ovarian cancer
about 5 hours ago
Merck offered a closer look at Keytruda's overall survival benefits in a...
ESMO: Keytruda, Padcev reduce risk of death by 50% in another massive showing in bladder cancer
about 5 hours ago
The standing ovation for Keytruda and Padcev in metastatic bladder cancer at...
ESMO: AZ, Daiichi unleash Enhertu's 2-fisted power, aiming to reshape early breast cancer landscape
about 5 hours ago
AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout...
Amgen, AZ's Tezspire gains 2nd FDA nod, upping the ante in its battle with Dupixent
about 22 hours ago
The FDA has endorsed Amgen and AstraZeneca’s Tezspire as an add-on maintenance...
Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics
1 day ago
Syngene: Transforming Monoclonal Antibody Manufacturing for the Next Wave of Biologics
Merck KGaA’s EMD Serono strikes MFN deal in Trump's fertility treatment pricing push
1 day ago
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer...
Sanofi gets one thumbs up, one thumbs down from Europe's CHMP
1 day ago
Europe’s Committee for Medicinal Products for Human Use (CHMP) has given a...
Fierce Pharma Asia—High-dollar licensing deals, Takeda's AI drug design pact and the finale of Novo vs. KBP
1 day ago
Dianthus and Boehringer Ingelheim headlined the latest round of licensing deals featuring...
Big pharma bets big on MASH with a new combo playbook
1 day ago
After Rezdiffra’s approval and Wegovy’s label expansion, the race is on in...
FDA names 9 first recipients of 1- to 2-month priority review vouchers
1 day ago
The FDA has handed out the first nine national priority vouchers, positioning...
ESMO: Results for AZ's Imfinzi in early bladder cancer type suggest it measures up to Pfizer candidate
1 day ago
Results presented by AstraZeneca from its phase 3 trial of Imfinzi in...
Eli Lilly's Verzenio secures overall survival win, bolstering early breast cancer case
1 day ago
Eli Lilly hopes its latest overall survival win could increase the adoption...